F-1/A: BYND Cannasoft Enterprises Inc. Announces Proposed Unit Offering

BYND Cannasoft Enterprises Inc. plans to offer units consisting of common shares, Series A warrants, and Series B warrants, with pre-funded units available for certain investors.

Summary

• BYND Cannasoft Enterprises Inc. is planning a public offering of units, each consisting of one common share, one Series A warrant, and two Series B warrants.
• Pre-funded units, containing pre-funded warrants, Series A warrants, and Series B warrants, will be offered to investors whose purchase would exceed a 4.99% ownership threshold.
• The company intends to use the proceeds for patent registrations, prototype production, sales & marketing of the EZ-G device, working capital, the permanent waiver of certain rights and obligations of an investor and general corporate purposes.
• The Series A warrants will expire 30 months from the issuance date, while the Series B warrants will expire five years from the issuance date.
• Aegis Capital Corp. is acting as the underwriter for the offering and has a 45-day option to purchase additional shares and/or warrants.
• The company's common shares are traded on the Nasdaq Capital Market under the symbol BCAN and were previously traded on the CSE under the symbol BYND, but the company has commenced the process for voluntary delisting from the CSE.
• The company is an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.

Sentiment

Score: 6

Explanation: The document is neutral. It outlines a proposed offering and associated risks, without expressing strong positive or negative sentiment.

Positives

• The offering aims to raise capital for key initiatives, including patent registrations and the EZ-G device.
• The company has the flexibility to use the proceeds for working capital and general corporate purposes.
• The company is an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.

Negatives

• The company has been notified by the Nasdaq that it no longer meets the $1 minimum bid price per share requirement.
• The company is in default on the BCSCs Reporting Issuers List pending resolution of comments from the British Columbia Securities Commission.
• The company has never generated any revenue from product sales and this part of our business may never be profitable.

Risks

• The company's executive offices and research and development facilities are located in Israel, and the current war between Israel and Hamas could disrupt operations.
• Failure to regain compliance with Nasdaq listing requirements could result in delisting.
• The company is dependent on a single client for the majority of its current revenues.
• The company may not be able to obtain all of the licenses or the necessary Good Practice Certifications required to operate our cannabis business as contemplated.
• The EZ-G Device may contain errors or defects, which could result in damage to our reputation, lost revenues, diverted development resources and increased service costs, warranty claims and litigation.

Future Outlook

The company expects to generate revenues from the New Cannabis CRM Platform in Q1 2024 and from the sale of cannabis or cannabis infused products in Q2 2024.

Industry Context

The company is positioning itself to capitalize on the growing female wellness industry and the medical cannabis market by leveraging its existing CRM expertise and developing new platforms and products.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares and warrants.
• The company's ability to execute its business plan and generate revenue will impact shareholder value.
• The company's employees and contractors may be affected by the company's financial performance and strategic decisions.
• The company's customers may benefit from the development of new CRM platforms and the EZ-G device.

Next Steps

• The company will file the Final Prospectus with the Commission.
• The company will seek to qualify or register the Units for offer and sale under the securities or Blue Sky laws of various jurisdictions.
• The company will continue to develop and test its New CRM Platform and New Cannabis CRM Platform.
• The company will pursue the final registration of the patents and establish a marketing and sales system for the EZ-G device.

Key Dates

Keywords

offering, warrants, common shares, BYND Cannasoft, securities, units, EZ-G, cannabis, pre-funded